Open orange pill bottle with rounded white pills
What’s the Evidence for Fluvoxamine in COVID-19? 
The US FDA’s decision not to grant an emergency use authorization for the antidepressant as a COVID-19 treatment highlights a lack of consensus among researchers about how to interpret clinical data on the drug.
ABOVE: © iStock.com, AndrewSoundarajan
What’s the Evidence for Fluvoxamine in COVID-19? 
What’s the Evidence for Fluvoxamine in COVID-19? 

The US FDA’s decision not to grant an emergency use authorization for the antidepressant as a COVID-19 treatment highlights a lack of consensus among researchers about how to interpret clinical data on the drug.

The US FDA’s decision not to grant an emergency use authorization for the antidepressant as a COVID-19 treatment highlights a lack of consensus among researchers about how to interpret clinical data on the drug.

ABOVE: © iStock.com, AndrewSoundarajan

pandemic

Woman in face shield and blue gown taking cotton swab of patient's mouth while patient sits inside of car
What You Should Know About New Omicron Subvariants
Natalia Mesa | May 17, 2022
The presence and spread of new, more-infectious and immune-evading variants show that the coronavirus is not done mutating.
Group of cells stained in either blue or green in a black background.
Diabetes Marker Linked to COVID-19 Severity in Mice
Alejandra Manjarrez | May 16, 2022
A sugar that’s less abundant in the blood of people with diabetes binds to SARS-CoV-2’s spike protein and disrupts the virus’s ability to fuse with cells.  
Ancient Secrets of the Plague
The Scientist Speaks - Ancient Secrets of the Plague
Niki Spahich, PhD | Nov 10, 2021
Simon Rasmussen discusses his research tracking the origins of the plague by analyzing ancient DNA.
Illustration of a doctor in medical coat and mask speaking at camera
Making the Most of Media Interviews
Katarina Zimmer | May 16, 2022
As the pandemic has underscored the importance—and benefits—of communicating science to the general public, it’s also highlighted the challenges that researchers can face in speaking with journalists.
Metal shelves densely packed with preserved tissue specimens of various sizes, all suspended in glass containers.
Evolution of 1918 Flu Virus Traced from Century-Old Samples
Dan Robitzski | May 10, 2022
The work reveals that the pandemic flu was likely the direct predecessor of the seasonal H1N1 flu that circulated for decades.
Characterizing Proteolysis During SARS-CoV-2 Infection
Characterizing Proteolysis During SARS-CoV-2 Infection
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | Nov 2, 2021
Edward Emmott will discuss mass spectrometry approaches to understand proteolysis during viral infection and their use in developing targeted strategies for COVID-19 treatment.
Illustration of scientists
Opinion: How Large International Collaborations Have Fared in the Pandemic
Sadye Paez, Giulio Formenti, Erich D. Jarvis | May 2, 2022
COVID-19 has challenged the progress of Big Science. Here are the lessons learned.
President Biden meeting with a group of people in the oval office
Biden Orders More Research on Long COVID
Christie Wilcox | Apr 6, 2022
A new presidential memorandum requires the Department of Health and Human Services to coordinate a government-wide push to generate a research action plan for the condition.
Discover new treatments for pandemic diseases
Treatments for Disease Pandemics
The Scientist Creative Services Team | Oct 29, 2021
Researchers develop new vaccines and therapeutics to combat the spread of infectious diseases.
A micrograph from the first US case of COVID-19, with SARS-CoV-2 virus particles in blue
SARS-CoV-2 Can Spread Via Cell-to-Cell Transmission
Catherine Offord | Apr 4, 2022
The virus’s ability to slip directly from one cell to another may help it avoid some of the body’s immune responses.
Illustration of the Earth heating up
Opinion: Climate Change Is Dangerous to Your Health
Mark Kessel, Rick Elbaum | Apr 4, 2022
In addition to causing more frequent natural disasters, global warming can have long-term health effects, which range from heat stress to mosquito-borne disease.
The Impact of Influenza
The Scientist Creative Services Team | Jul 13, 2021
Richard Webby and Edward Hutchinson discuss influenza viruses—the development of new strains, how they mediate virulence, and their threat to human society.
Child with head tilted back receiving oral polio vaccine
Mass Polio Vaccination Effort Underway in East Africa
Natalia Mesa | Mar 18, 2022
Malawi and its neighbors plan to vaccinate 9.4 million children against polio in the coming week to combat a suspected outbreak.
Vector abstract world around coronavirus macro illustration.
Living the Life Pandemic
Bob Grant | Mar 16, 2022
The first part of 2022 is giving us a glimpse of humanity’s future relationship with COVID-19.
Securing the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case Study
The Scientist Creative Services Team in collaboration with Sartorius Corporation | Mar 29, 2021
Nicholas Hutchings will discuss how recombinant antibody technology can speed up the response to a pandemic.
old-fashioned, black and white alarm clock with words "the end"
Editorial: When Will This Pandemic Officially End?
Bob Grant | Mar 11, 2022
And does it even matter?
illustration of human brain
COVID-19 Linked to Neural Changes
Shawna Williams | Mar 7, 2022
A study that examined the brains of people before and after SARS-CoV-2 infection found a decrease in brain volume and damage to olfactory areas compared with controls.
Fast-Tracking COVID-19 Research
The Scientist Creative Services Team in collaboration with Sartorius Corporation | Mar 17, 2021
Identifying molecular targets for SARS-CoV-2 therapeutics.
A young white-tailed deer in the snow
Possible Case of Deer-To-Human SARS-CoV-2 Transmission
Catherine Offord | Mar 3, 2022
Canadian researchers identify a highly mutated variant of the virus in white-tailed deer and link it to a human COVID-19 case in the region—though they emphasize that the infection risk to people is low.